Dovastrop

Dovastrop

dobutamine

Manufacturer:

Kimia Farma

Marketer:

Pharmasolindo
Concise Prescribing Info
Contents
Dobutamine HCl
Indications/Uses
For inotropic myocardial support in the treatment of adults w/ acute congestive heart disease or cardiogenic shock.
Dosage/Direction for Use
IV infusion Usual dose: 2.5-10 mcg/kg/min.
Contraindications
Hypersensitivity. Patients w/ idiopathic hypertrophic subaortic stenosis.
Special Precautions
Continuously monitor ECG, BP, cardiac filling pressure, cardiac output during treatment. Hypovolemia should be corrected prior to treatment. Post MI. Patients w/ CAD, arterial HTN, atrial fibrillation. May cause ectopic ventricle activity. Pregnancy, lactation. Childn.
Adverse Reactions
Nausea, headache, palpitation, dyspnea, chest pain.
Drug Interactions
Nitroprussides, β-adrenoreceptor inhibitor.
MIMS Class
Cardiac Drugs
ATC Classification
C01CA07 - dobutamine ; Belongs to the class of adrenergic and dopaminergic cardiac stimulants excluding glycosides. Used in the treatment of hypotension.
Presentation/Packing
Form
Dovastrop inj 50 mg/mL
Packing/Price
5 mL x 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in